Related references
Note: Only part of the references are listed.Intramolecular Hydrogen Bonding in Medicinal Chemistry
Bernd Kuhn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Adding calorimetric data to decision making in lead discovery: a hot tip
John E. Ladbury et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Physiochemical drug properties associated with in vivo toxicological outcomes
Jason D. Hughes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Do enthalpy and entropy distinguish first in class from best in class?
Ernesto Freire
DRUG DISCOVERY TODAY (2008)
The influence of drug-like concepts on decision-making in medicinal chemistry
Paul D. Leeson et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Global mapping of pharmacological space
Gaia V. Paolini et al.
NATURE BIOTECHNOLOGY (2006)
Dependence of molecular properties on proteomic family for marketed oral drugs
Michal Vieth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Drugs targeting protein-protein interactions
Patrick Chene
CHEMMEDCHEM (2006)
Testing the conformational hypothesis of passive membrane permeability using synthetic cyclic peptide diastereomers
T Rezai et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
Oral delivery of G protein-coupled receptor modulators: An explanation for the observed class difference
K Beaumont et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
The evolution of synthetic oral drug properties
JR Proudfoot
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Small-molecule inhibitors of protein-protein interactions: Progressing towards the dream
MR Arkin et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Lipid bilayer topology of the transmembrane α-helix of M13 major coat protein and bilayer polarity profile by site-directed fluorescence spectroscopy
RBM Koehorst et al.
BIOPHYSICAL JOURNAL (2004)
Time-related differences in the physical property profiles of oral drugs
PD Leeson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Characteristic physical properties and structural fragments of marketed oral drugs
M Vieth et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
A novel once-daily protease inhibitor
PJ Piliero
DRUGS OF TODAY (2004)
A comparison of physiochemical property profiles of development and marketed oral drugs
MC Wenlock et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Discovery of a thieno[2,3-d]pyrimidine-2,4-dione bearing a p-methoxyureidophenyl moiety at the 6-position:: A highly potent and orally bioavailable non-peptide antagonist for the human luteinizing hormone-releasing hormone receptor
S Sasaki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK1 receptor antagonist
VA Ashwood et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Acyl substitution at the ortho position of anilides enhances oral bioavailability of thiophene sulfonamides:: TBC3214, an ETA selective endothelin antagonist
CD Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties
P Ertl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
